A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia
Clinical trial NCT03771664 · TERMINATED
Trial details
- NCT number
- NCT03771664
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-04
- Primary completion
- 2019-12-20
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.